USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/1794
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBuruiană, Sanda
dc.contributor.authorCorcimaru, Ion
dc.contributor.authorRobu, Maria
dc.contributor.authorMusteaţă, Larisa
dc.contributor.authorGladâş, Valentina
dc.contributor.authorChiu, Maria
dc.contributor.authorPopescu, Maria
dc.contributor.authorMunteanu, Victor
dc.date.accessioned2019-06-22T12:43:26Z-
dc.date.available2019-06-22T12:43:26Z-
dc.date.issued2010
dc.identifier.citationBURUIANĂ, Sanda, CORCIMARU, Ion et al. Aspecte clinice ale limfoamelor non-Hodgkin indolente. In: Anale Ştiințifice ale USMF “Nicolae Testemiţanu”. Ed. a 11-a. Chișinău: CEP Medicina, 2010, vol. 3: Probleme actuale in medicina interna, pp. 335-339en_US
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/1794-
dc.descriptionCatedra Hematologie şi Oncologie USMF “N.Testemiţanu”en_US
dc.description.abstractThe clinical features of indolent non-Hodgkin’s lymphomas (NHL) have been studied in 167 patients aged 20 to 80. It has been noticed that the indolent non-Hodgkin’s lymphomas rarely develop in young people, and the frequency increases with age, reaching the top in patients over 60. The onset of indolent NHL predominated in spleen (35.9%), peripheral lymph nodes (31.1%), Waldeyer’s lymphoid ring (19.2%). Most rarely the indolent NHL primarily developed in the gastrointestinal tract (9.0%), abdominal lymph nodes (3.6%), mediastinal lymph nodes (1.2%). The bone marrow was involved most often during the disease dissemination (84.0%). The overall 5-year survival in patients with indolent non-Hodgkin’s lymphomas was 55.3%. Au fost studiate manifestările clinice la 167 pacienţi cu limfoame non-Hodgkin (NHL) indolente în vârsta de la 20 până la 80 de ani. S-a observat că LNH indolente rar se dezvoltă la persoanele tinere. Frecvenţa lor creşte odată cu vârsta, atingând maximum la pacienţi în vârsta de peste 60 de ani. Debutul LNH indolente a avut loc mai frecvent în splină (35,9%), ganglionii limfatici periferici (31,1%), inelul limfatic Waldeyer (19,2%). Rar s-a dezvoltat LNH indolente primar în tractul gastrointestinal (9,0%), ganglionii limfatici abdominali (3,6%) şi mediastinali (1,2%). La etapa de generalizare a LNH frecvent a fost afectată măduva oaselor (84,0%). Supravieţuirea pacienţilor cu LNH indolente peste 5 ani a fost egală cu 55,3%.en_US
dc.language.isoroen_US
dc.publisherCEP Medicinaen_US
dc.titleAspecte clinice ale limfoamelor non-Hodgkin indolenteen_US
dc.title.alternativeClinical features of indolent non-Hodgkin’s lymphomasen_US
dc.typeArticleen_US
Appears in Collections:Hematologie, oncologie

Files in This Item:
File Description SizeFormat 
ASPECTE_CLINICE_ALE_LIMFOAMELOR_NON_HODGKIN_INDOLENTE.pdf226.41 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback